We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AACC and Life Diagnostics Partner to Relaunch AACC Middle East

By LabMedica International staff writers
Posted on 10 Feb 2022
Print article
Image: AACC Middle East (Photo courtesy of AACC)
Image: AACC Middle East (Photo courtesy of AACC)

The American Association for Clinical Chemistry (AACC Washington, D.C., USA) has announced a new collaboration with Life Diagnostics (Abu Dhabi, UAE) to relaunch AACC Middle East which will bring AACC's world-renowned education and scientific programs paired with a dynamic exhibit to Dubai, UAE, November 5-6, 2022.

AACC Middle East was first launched in 2018 as part of AACC's strategy to improve health outcomes globally, and it drew an overwhelmingly positive response during its initial two-year run. Like so many in-person events, it then went on hiatus after the emergence of COVID-19. However, as the pandemic has persisted and continued to challenge laboratory medicine professionals - the people on the frontlines of coronavirus testing worldwide - it has become more important than ever that AACC Middle East be resumed in order to provide lab professionals with the educational programming and networking opportunities they need at this crucial time.

AACC will work closely with Life Diagnostics in order to relaunch AACC Middle East for this purpose. The event's scientific program will feature experts from the US and the Middle East who will share gold standard, actionable information about the latest in clinical testing. Attendees will be able to come together safely and in-person with leaders in the field to share lessons learned from the pandemic to date. In addition, the exposition floor of AACC Middle East will feature the latest innovations in every area of clinical testing, including coronavirus testing, artificial intelligence (AI), mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing (NGS), point of care (POC), and automation.

"We at AACC are very excited to partner with Life Dx and other content experts in the Middle East to bring this essential conference back to the region," said AACC President Dr. Stephen R. Master. "For the past two years, laboratory medicine professionals around the world have heroically risen to the challenges we've faced during the pandemic, and I hope this meeting will fuel attendees' innovation and create new research collaborations and connections with colleagues who understand what everyone in the field has been through over these past many months."

Related Links:
AACC 
Life Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more